These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 9874785

  • 1. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
    Aoki M, Hecht A, Kruse U, Kemler R, Vogt PK.
    Proc Natl Acad Sci U S A; 1999 Jan 05; 96(1):139-44. PubMed ID: 9874785
    [Abstract] [Full Text] [Related]

  • 2. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
    Orsulic S, Huber O, Aberle H, Arnold S, Kemler R.
    J Cell Sci; 1999 Apr 05; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
    [Abstract] [Full Text] [Related]

  • 3. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
    Kolligs FT, Hu G, Dang CV, Fearon ER.
    Mol Cell Biol; 1999 Aug 05; 19(8):5696-706. PubMed ID: 10409758
    [Abstract] [Full Text] [Related]

  • 4. Signaling through beta-catenin and Lef/Tcf.
    Novak A, Dedhar S.
    Cell Mol Life Sci; 1999 Oct 30; 56(5-6):523-37. PubMed ID: 11212302
    [Abstract] [Full Text] [Related]

  • 5. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T, Ninomiya-Tsuji J, Matsumoto K.
    Mol Cell Biol; 2003 Feb 30; 23(4):1379-89. PubMed ID: 12556497
    [Abstract] [Full Text] [Related]

  • 6. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin.
    Hsu SC, Galceran J, Grosschedl R.
    Mol Cell Biol; 1998 Aug 30; 18(8):4807-18. PubMed ID: 9671490
    [Abstract] [Full Text] [Related]

  • 7. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV, Fryer CJ, Jones KA.
    Genes Dev; 2001 Dec 15; 15(24):3342-54. PubMed ID: 11751639
    [Abstract] [Full Text] [Related]

  • 8. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H, Mao J, Li L, Wu D.
    J Biol Chem; 1999 Oct 22; 274(43):30419-23. PubMed ID: 10521419
    [Abstract] [Full Text] [Related]

  • 9. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
    Henderson BR, Galea M, Schuechner S, Leung L.
    J Biol Chem; 2002 Jul 05; 277(27):24258-64. PubMed ID: 11986304
    [Abstract] [Full Text] [Related]

  • 10. The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis.
    Vleminckx K, Kemler R, Hecht A.
    Mech Dev; 1999 Mar 05; 81(1-2):65-74. PubMed ID: 10330485
    [Abstract] [Full Text] [Related]

  • 11. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
    Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF.
    J Biol Chem; 2002 Sep 06; 277(36):33398-410. PubMed ID: 12052822
    [Abstract] [Full Text] [Related]

  • 12. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F, Robinet C, Augé N, Thiers JC, Garcia V, Cambus JP, Salvayre R, Nègre-Salvayre A.
    Cancer Res; 2005 Jan 15; 65(2):526-32. PubMed ID: 15695395
    [Abstract] [Full Text] [Related]

  • 13. Requirement for a nuclear function of beta-catenin in Wnt signaling.
    Cong F, Schweizer L, Chamorro M, Varmus H.
    Mol Cell Biol; 2003 Dec 15; 23(23):8462-70. PubMed ID: 14612392
    [Abstract] [Full Text] [Related]

  • 14. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
    Kolligs FT, Nieman MT, Winer I, Hu G, Van Mater D, Feng Y, Smith IM, Wu R, Zhai Y, Cho KR, Fearon ER.
    Cancer Cell; 2002 Mar 15; 1(2):145-55. PubMed ID: 12086873
    [Abstract] [Full Text] [Related]

  • 15. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
    Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F.
    Mol Cell Biol; 2002 Feb 15; 22(4):1172-83. PubMed ID: 11809808
    [Abstract] [Full Text] [Related]

  • 16. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A, Weiske J, Huber O.
    Cell Mol Life Sci; 2005 Mar 15; 62(5):606-18. PubMed ID: 15747065
    [Abstract] [Full Text] [Related]

  • 17. Wnt-independent beta-catenin transactivation in tumor development.
    Lu Z, Hunter T.
    Cell Cycle; 2004 May 15; 3(5):571-3. PubMed ID: 15107603
    [Abstract] [Full Text] [Related]

  • 18. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
    Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B, Ben-Ze'ev A.
    J Cell Biol; 1998 Jun 15; 141(6):1433-48. PubMed ID: 9628899
    [Abstract] [Full Text] [Related]

  • 19. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER.
    Genes Dev; 2000 Jun 01; 14(11):1319-31. PubMed ID: 10837025
    [Abstract] [Full Text] [Related]

  • 20. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ, Burgering BM, van de Wetering M, Clevers HC.
    Int Immunol; 1999 Mar 01; 11(3):317-23. PubMed ID: 10221643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.